BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35830849)

  • 1. Minichromosome Maintenance 4 Is Associated with Cancer Stemness and Poor Survival of Patients with Gastric Cancer.
    Katsuya N; Ishikawa A; Kido A; Fukui T; Kobayashi G; Sekino Y; Uraoka N; Babasaki T; Yasui W; Sentani K; Oue N
    Pathobiology; 2023; 90(3):147-154. PubMed ID: 35830849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
    Sun Z; Gao X; Zabkiewicz C; Ruge F; Xie M; Cai S; Sun PH; Griffiths P; Pugh MR; Ji J; Jiang WG; Ye L
    Int J Oncol; 2020 Sep; 57(3):813-824. PubMed ID: 32705152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma.
    Kobayashi G; Hayashi T; Sentani K; Uraoka N; Fukui T; Kido A; Katsuya N; Ishikawa A; Babasaki T; Sekino Y; Nose H; Arihiro K; Hinata N; Oue N
    Diagn Pathol; 2023 Sep; 18(1):106. PubMed ID: 37737200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of claspin overexpression and its association with spheroid formation in gastric cancer.
    Kobayashi G; Sentani K; Hattori T; Yamamoto Y; Imai T; Sakamoto N; Kuraoka K; Oue N; Sasaki N; Taniyama K; Yasui W
    Hum Pathol; 2019 Feb; 84():8-17. PubMed ID: 30240769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis.
    Li C; Zhang J; Zhou Y; Li B
    Dig Liver Dis; 2021 Apr; 53(4):509-516. PubMed ID: 33478874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.
    Wang N; She J; Liu W; Shi J; Yang Q; Shi B; Hou P
    Cell Cycle; 2015; 14(5):732-43. PubMed ID: 25590580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G364R mutation of MCM4 detected in human skin cancer cells affects DNA helicase activity of MCM4/6/7 complex.
    Ishimi Y; Irie D
    J Biochem; 2015 Jun; 157(6):561-9. PubMed ID: 25661590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
    Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
    Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDIT3 modulates cancer stemness in gastric cancer by directly regulating CEBPβ.
    Lin H; Liu S; Gao W; Liu H
    J Pharm Pharmacol; 2020 Jun; 72(6):807-815. PubMed ID: 32189359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin inhibits gastric cancer progression through activating the ERK-P65-miR23a/27a/24 axis.
    Zu LD; Peng XC; Zeng Z; Wang JL; Meng LL; Shen WW; Hu CT; Yang Y; Fu GH
    J Exp Clin Cancer Res; 2018 Jun; 37(1):115. PubMed ID: 29866191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
    Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
    Jia S; Qu T; Wang X; Feng M; Yang Y; Feng X; Ma R; Li W; Hu Y; Feng Y; Ji K; Li Z; Jiang W; Ji J
    PLoS One; 2017; 12(4):e0175058. PubMed ID: 28422983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
    PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
    Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
    J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GNA13 as a prognostic factor and mediator of gastric cancer progression.
    Zhang JX; Yun M; Xu Y; Chen JW; Weng HW; Zheng ZS; Chen C; Xie D; Ye S
    Oncotarget; 2016 Jan; 7(4):4414-27. PubMed ID: 26735177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated β-arrestin1 predicts poor prognosis and promotes metastasis via AKT/ERK signaling pathway in gastric cancer.
    Xu T; Shen G; Cheng M; Wu X; Xu Y; Hu S
    Pathol Res Pract; 2020 Dec; 216(12):153262. PubMed ID: 33129195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
    Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
    Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.